Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Tessari

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Pediatric Nephrology (Berlin, Germany)|June 19, 2026
Hemoadsorption in acute pediatric carbamazepine intoxication: a case report and systematic review of extracorporeal therapiesDavide Visentin, Germana Longo, Anna Tessari, et al.
Pharmacotherapy|December 26, 2022
Is ketamine infusion effective and safe as an adjuvant of sedation in the PICU? Results from the Ketamine Infusion Sedation Study (KISS)Anna Tessari, Francesca Sperotto, Federico Pece, et al.
Breast (Edinburgh, Scotland)|September 7, 2018
Expression of NY-ESO-1, MAGE-A3, PRAME and WT1 in different subgroups of breast cancer: An indication to immunotherapy?Anna Tessari, Lorenzo Pilla, Damian Silvia, et al.
Journal of Cancer Metastasis and Treatment|November 15, 2021
RANBP9 as potential therapeutic target in non-small cell lung cancerAnna Tessari, Shimaa H A Soliman, Arturo Orlacchio, et al.
Cancers|July 2, 2021
Integrative Transcriptomic Analysis Reveals Distinctive Molecular Traits and Novel Subtypes of Collecting Duct CarcinomaChiara Gargiuli, Pierangela Sepe, Anna Tessari, et al.
Plos One|September 13, 2018
Genetic ablation of interacting with Spt6 (Iws1) causes early embryonic lethalityArturo Orlacchio, Aaron E Stark, Claudia Foray, et al.
Breast Cancer (Tokyo, Japan)|January 7, 2017
Complete remission in metastatic breast cancer: expecting the unexpected-results of a cross-sectional studyGiulia Galli, Anna Tessari, Luca Porcu, et al.
ESMO Open|February 22, 2018
Phase I study of tomuzotuximab, a glycoengineered therapeutic antibody against the epidermal growth factor receptor, in patients with advanced carcinomasWalter Fiedler, Sara Cresta, Henning Schulze-Bergkamen, et al.
Cell Death and Differentiation|August 3, 2023
A novel auxin-inducible degron system for rapid, cell cycle-specific targeted proteolysisMarina Capece, Anna Tessari, Joseph Mills, et al.
Cancers|July 16, 2020
NCL Inhibition Exerts Antineoplastic Effects against Prostate Cancer Cells by Modulating Oncogenic MicroRNAsTyler Sheetz, Joseph Mills, Anna Tessari, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Pediatric Nephrology (Berlin, Germany)|June 19, 2026
Hemoadsorption in acute pediatric carbamazepine intoxication: a case report and systematic review of extracorporeal therapiesDavide Visentin, Germana Longo, Anna Tessari, et al.
Pharmacotherapy|December 26, 2022
Is ketamine infusion effective and safe as an adjuvant of sedation in the PICU? Results from the Ketamine Infusion Sedation Study (KISS)Anna Tessari, Francesca Sperotto, Federico Pece, et al.
Breast (Edinburgh, Scotland)|September 7, 2018
Expression of NY-ESO-1, MAGE-A3, PRAME and WT1 in different subgroups of breast cancer: An indication to immunotherapy?Anna Tessari, Lorenzo Pilla, Damian Silvia, et al.
Journal of Cancer Metastasis and Treatment|November 15, 2021
RANBP9 as potential therapeutic target in non-small cell lung cancerAnna Tessari, Shimaa H A Soliman, Arturo Orlacchio, et al.
Cancers|July 2, 2021
Integrative Transcriptomic Analysis Reveals Distinctive Molecular Traits and Novel Subtypes of Collecting Duct CarcinomaChiara Gargiuli, Pierangela Sepe, Anna Tessari, et al.
Plos One|September 13, 2018
Genetic ablation of interacting with Spt6 (Iws1) causes early embryonic lethalityArturo Orlacchio, Aaron E Stark, Claudia Foray, et al.
Breast Cancer (Tokyo, Japan)|January 7, 2017
Complete remission in metastatic breast cancer: expecting the unexpected-results of a cross-sectional studyGiulia Galli, Anna Tessari, Luca Porcu, et al.
ESMO Open|February 22, 2018
Phase I study of tomuzotuximab, a glycoengineered therapeutic antibody against the epidermal growth factor receptor, in patients with advanced carcinomasWalter Fiedler, Sara Cresta, Henning Schulze-Bergkamen, et al.
Cell Death and Differentiation|August 3, 2023
A novel auxin-inducible degron system for rapid, cell cycle-specific targeted proteolysisMarina Capece, Anna Tessari, Joseph Mills, et al.
Cancers|July 16, 2020
NCL Inhibition Exerts Antineoplastic Effects against Prostate Cancer Cells by Modulating Oncogenic MicroRNAsTyler Sheetz, Joseph Mills, Anna Tessari, et al.
Pageof 4